U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Non-Clinical Safety Lead - Non-Clinical Safety Evaluation

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$168k - $220.5k /yr

About the Job

Requirements

  • A PhD in Toxicology, Pharmacology, or a related discipline, or an equivalent Master’s degree or Doctor of Veterinary Medicine degree with experience.
  • At least 5 years of experience in non-clinical safety, preferably in pharma or biotech.
  • Deep understanding of regulatory processes and regulatory toxicology.
  • Experience managing and forecasting non-clinical safety budgets.
  • Ability to produce high-quality reports and submission documents with subject matter expert support.

Responsibilities

  • Provide scientific leadership for non-clinical safety across discovery and development programs.
  • Lead, communicate, and execute non-clinical safety strategies aligned with clinical development goals.
  • Develop integrated non-clinical safety plans supporting innovative programs.
  • Ensure timely delivery of high-quality non-clinical data and global regulatory documentation.
  • Represent UCB in interactions with regulatory authorities and external partners.
  • Provide non-clinical safety expertise to discovery and development projects.
  • Define, lead, and implement non-clinical safety strategies across programs.
  • Partner with clinical teams to ensure robust preclinical data supports clinical trial design.
  • Contribute to global regulatory submissions, including Investigator’s Brochures, Briefing Books, Investigational New Drug applications, and New Drug Applications/Biologics License Applications, and interact with regulatory authorities.
  • Oversee the design, review, and interpretation of non-clinical studies.
  • Manage non-clinical safety programs, including budgets.

Desired Qualifications

  • Accredited or registered toxicologist.
  • Experience in gene and cell therapy and/or other novel modalities.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs